2009 Chemotherapy FDA 
The Thyroid Pharmacist
AUGUST 1, 2025
Thyroid Medication Safety During Pregnancy and Breastfeeding Thyroid medications are known to be safe during pregnancy and are rated by the FDA as a category A drug for pregnancy, which means there is no evidence of harm to the fetus. Geneva: World Health Organization; 2009. 2009 Nov;18(11):1847-56. 2009 Aug;55(8):797-8.
pharmaphorum
NOVEMBER 28, 2021
The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival. Jazz acquired rights to Sativex when it completed its $7.2
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
DECEMBER 13, 2023
Antiemetics may also reduce radiation-associated or chemotherapy-induced nausea resulting from cancer treatment. Kaopectate tablet and liquid suspension Bismuth subsalicylate is FDA-approved for treating nausea and vomiting. These medications can help with motion sickness, vertigo, postoperative nausea, and morning sickness.
The Thyroid Pharmacist
SEPTEMBER 20, 2024
Plecanatide : This is one of the newest medications for IBS-C that has been approved by the FDA. Tenapanor : Tenapanor was approved by the FDA in September of 2019 for IBS-C. [45] As the intestines are made of smooth muscles, a reduction in the action of these muscles can slow down digestion and cause constipation. 2012.10.028. [6]
PharmaShots
MARCH 29, 2023
Lupin has earned the US FDA approval for the generic version of Banzel as Rufinamide Oral Suspension. It is the only drug in its class of chemotherapy and is developed from the natural substance found in a sea sponge. The exact mechanism of action is uncertain. Glenmark has also released its generic drug version in the US market.
pharmaphorum
JULY 1, 2025
The new data comes from the FORTITUDE-101 looking at bemarituzumab plus chemotherapy as a front-line therapy for FGFR2b-positive advanced gastric cancer, and has revealed a significant improvement in overall survival (OS) compared to placebo plus chemo. pharmaphorum – an EVERSANA company The rights of trademark owners are acknowledged.
Expert insights. Personalized for you.
Let's personalize your content